193 related articles for article (PubMed ID: 19761616)
1. The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells.
Workman HC; Miller JK; Ingalla EQ; Kaur RP; Yamamoto DI; Beckett LA; Young LJ; Cardiff RD; Borowsky AD; Carraway KL; Sweeney C; Carraway KL
Breast Cancer Res; 2009; 11(5):R70. PubMed ID: 19761616
[TBL] [Abstract][Full Text] [Related]
2. Comparison of MUC4 expression in primary pancreatic cancer and paired lymph node metastases.
Ansari D; Urey C; Gundewar C; Bauden MP; Andersson R
Scand J Gastroenterol; 2013 Oct; 48(10):1183-7. PubMed ID: 24047396
[TBL] [Abstract][Full Text] [Related]
3. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer.
Tamura Y; Higashi M; Kitamoto S; Yokoyama S; Osako M; Horinouchi M; Shimizu T; Tabata M; Batra SK; Goto M; Yonezawa S
PLoS One; 2012; 7(11):e49251. PubMed ID: 23152882
[TBL] [Abstract][Full Text] [Related]
4. The role of membrane mucin MUC4 in breast cancer metastasis.
Dreyer CA; VanderVorst K; Free S; Rowson-Hodel A; Carraway KL
Endocr Relat Cancer; 2021 Nov; 29(1):R17-R32. PubMed ID: 34726614
[TBL] [Abstract][Full Text] [Related]
5. The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms.
Workman HC; Sweeney C; Carraway KL
Cancer Res; 2009 Apr; 69(7):2845-52. PubMed ID: 19293191
[TBL] [Abstract][Full Text] [Related]
6. MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells.
Mukhopadhyay P; Lakshmanan I; Ponnusamy MP; Chakraborty S; Jain M; Pai P; Smith LM; Lele SM; Batra SK
PLoS One; 2013; 8(2):e54455. PubMed ID: 23408941
[TBL] [Abstract][Full Text] [Related]
7. Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.
Rowson-Hodel AR; Wald JH; Hatakeyama J; O'Neal WK; Stonebraker JR; VanderVorst K; Saldana MJ; Borowsky AD; Sweeney C; Carraway KL
Oncogene; 2018 Jan; 37(2):197-207. PubMed ID: 28892049
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression profiles of mucin antigens in salivary gland mucoepidermoid carcinoma: MUC4- and MUC6-negative expression predicts a shortened survival in the early postoperative phase.
Honjo K; Hiraki T; Higashi M; Noguchi H; Nomoto M; Yoshimura T; Batra SK; Yonezawa S; Semba I; Nakamura N; Tanimoto A; Yamada S
Histol Histopathol; 2018 Feb; 33(2):201-213. PubMed ID: 28649694
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer.
Jain M; Venkatraman G; Moniaux N; Kaur S; Kumar S; Chakraborty S; Varshney GC; Batra SK
PLoS One; 2011; 6(8):e23344. PubMed ID: 21886786
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of gap junction protein--connexin 32 in lymph node metastases of human ductal breast cancer.
Kanczuga-Koda L; Sulkowska M; Koda M; Rutkowski R; Sulkowski S
Folia Histochem Cytobiol; 2007; 45 Suppl 1():S175-80. PubMed ID: 18292829
[TBL] [Abstract][Full Text] [Related]
11. TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer.
Mercogliano MF; De Martino M; Venturutti L; Rivas MA; Proietti CJ; Inurrigarro G; Frahm I; Allemand DH; Deza EG; Ares S; Gercovich FG; Guzmán P; Roa JC; Elizalde PV; Schillaci R
Clin Cancer Res; 2017 Feb; 23(3):636-648. PubMed ID: 27698002
[TBL] [Abstract][Full Text] [Related]
12. Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line.
Nagy P; Friedländer E; Tanner M; Kapanen AI; Carraway KL; Isola J; Jovin TM
Cancer Res; 2005 Jan; 65(2):473-82. PubMed ID: 15695389
[TBL] [Abstract][Full Text] [Related]
13. Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer.
Ghaffari A; Hoskin V; Turashvili G; Varma S; Mewburn J; Mullins G; Greer PA; Kiefer F; Day AG; Madarnas Y; SenGupta S; Elliott BE
Breast Cancer Res; 2019 Jan; 21(1):12. PubMed ID: 30678714
[TBL] [Abstract][Full Text] [Related]
14. Specific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer.
Rozenchan PB; Pasini FS; Roela RA; Katayama ML; Mundim FG; Brentani H; Lyra EC; Brentani MM
Tumour Biol; 2015 Dec; 36(12):9589-97. PubMed ID: 26142737
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of both MDR1 and MMP-2 genes in metastasized lymph node of invasive ductal breast cancer.
Lu LS; Chen L; Ding WX; Li K; Wu JJ
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2037-43. PubMed ID: 23280016
[TBL] [Abstract][Full Text] [Related]
16. PRC2/EED-EZH2 complex is up-regulated in breast cancer lymph node metastasis compared to primary tumor and correlates with tumor proliferation in situ.
Yu H; Simons DL; Segall I; Carcamo-Cavazos V; Schwartz EJ; Yan N; Zuckerman NS; Dirbas FM; Johnson DL; Holmes SP; Lee PP
PLoS One; 2012; 7(12):e51239. PubMed ID: 23251464
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer primary tumor ER expression pattern predicts its expression concordance in matched synchronous lymph node metastases.
Zhao J; Hu C; Wang C; Yu W; Guo Y; Shi M; Shui Y; Wei Q
BMC Cancer; 2018 Dec; 18(1):1290. PubMed ID: 30587150
[TBL] [Abstract][Full Text] [Related]
18. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein and MRP1 expression in axillary lymph node metastases of breast cancer patients.
Zöchbauer-Müller S; Filipits M; Rudas M; Brunner R; Krajnik G; Suchomel R; Schmid K; Pirker R
Anticancer Res; 2001; 21(1A):119-24. PubMed ID: 11299725
[TBL] [Abstract][Full Text] [Related]
20. Reduced MUC4 expression is a late event in breast carcinogenesis and is correlated with increased infiltration of immune cells as well as promoter hypermethylation in invasive breast carcinoma.
Cho JS; Park MH; Lee JS; Yoon JH
Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):44-53. PubMed ID: 24992172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
